2021 Fall Conference | C16 - Valued-based “Why the Heck Should We” Care?
Program Materials Program Evaluations
| 12:30 PM - 01:50 PM EDT | Speaker |
Practice Management 6: Valued-based “Why the Heck Should We” Care?
Joseph V. Fritz, PhD, Daniel J. Ackerman, MD, FÂ鶹´«Ã½Ó³» |
| 01:50 PM - 02:00 PM EDT | Q&A |
LIVE Q&A
Brad C. Klein, MD, MBA, FÂ鶹´«Ã½Ó³», Pearce J. Korb, MD, FÂ鶹´«Ã½Ó³», Joseph V. Fritz, PhD, Daniel J. Ackerman, MD, FÂ鶹´«Ã½Ó³», David A. Evans, MBA, DÂ鶹´«Ã½Ó³» |
| Brad C. Klein, MD, MBA, FÂ鶹´«Ã½Ó³» | Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Pearce J. Korb, MD, FÂ鶹´«Ã½Ó³» | Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Â鶹´«Ã½Ó³» Resources. |
| Joseph V. Fritz, PhD | Dr. Fritz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroNetPro. Dr. Fritz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fritz has a non-compensated relationship as a Board Member with Population Health Collaborative that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Fritz has a non-compensated relationship as a Managing Director with NeuroNet GPO that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Daniel J. Ackerman, MD, FÂ鶹´«Ã½Ó³» | Dr. Ackerman has nothing to disclose. |
| David A. Evans, MBA, DÂ鶹´«Ã½Ó³» | Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI. |